ライフサイエンスコーパス: donor

1 ve oxygen species (ROS)-activated persulfide donor.

2 and, quite surprisingly, also as a suitable donor.

3 on products beyond simple integration of the donor.

4 rable to patients with a KIR-disadvantageous donor.

5 e from a matched sibling versus an unrelated donor.

6 en if the kidney came from an extremely aged donor.

7 ied the [2Fe-2S]-containing GLRX5 as cluster donor.

8 increasing the fluorescence lifetime of the donor.

9 ity lipoprotein, and dependency on the human donor.

10 the likelihood of identifying an acceptable donor.

11 ival of cardiac allografts from CMV-infected donors.

12 28 + 0.24; P = 0.0001) were lower in Group A donors.

13 ent and the selection of convalescent plasma donors.

14 n donors along with the changing position of donors.

15 MCs), and leukocytes were obtained from four donors.

16 DD) donors but do not measure potential DCDD donors.

17 in transplanted kidneys, both from pediatric donors.

18 s to predict soft biometric traits about the donors.

19 ncourage consideration of all possible organ donors.

20 re split: 54% from adult, 46% from pediatric donors.

21 in selecting appropriate convalescent serum donors.

22 a and peripheral retina of seven adult human donors.

23 e 3 common cold coronaviruses in many of the donors.

24 tract funding from individuals and corporate donors.

25 iding information on the level of individual donors.

26 s, regardless hyperglycemia status of oocyte donors.

27 ata from multiple tissues from healthy human donors.

28 dditional flexibility in converting electron donors.

29 olated from 151 multiethnic heart transplant donors.

30 ets required from either cadaveric or living donors.

31 l negative consequences of COVID-19-positive donors.

32 uteri from living donors and 2 from deceased donors.

33 schemic heart failure (2%), or healthy blood donors (0.3%).

34 th more zero HLA mismatch (8% vs 4%), living donors (26% vs 20%), and lymphodepleting induction (64%

35 d for auto+/allo+ pairs; n = 64) against 110 donors (338 tests) and show that, in our cohort, positiv

36 rgan harvested (pneumonia prevalence in lung donors (9.7%) vs nondonors (49.2%); p = 0.0002).

37 the 1494 samples tested from first-time male donors, 9 (0.6%; 95% CI, 0.03% to 1.1%) had tenofovir an

38 We report a new donor-acceptor (D-A) system, PyTz-COF that was construct

39 SET) event involving a photoexcited electron-donor-acceptor complex between an NHPI ester and a Hantz

40 A nucleophilic retro-Claisen ring-opening of donor-acceptor cyclobutenes, formed with high stereocont

41 ng hypervalent iodine reagents, reactions of donor-acceptor cyclopropanols, and pericylic reactions.

42 y activated delayed fluorescence (TADF) from donor-acceptor exciplexes that are either protonated (H)

43 s are useful platforms for studying electron-donor/acceptor interactions and dynamics therein.

44 an ultrahigh antenna effect (33.1) at a high donor/acceptor ratio (250:1).

45 cycle who received EBV-CTLs from a different donor achieved CR or durable PR (60%) and survived longe

46 concomitant increase in younger HCV viremic donors after brain death being identified.

47 We stratified by donor age (<18, 18-34, and 35+ years) and KDPI (<35% and

48 D-MELD (donor age x recipients' MELD) was associated with postop

49 ed using the variables such as recipient and donor age, indication of LT.

50 The use of corneas from donors aged >=80 for DMEK surgery may therefore be a pro

51 roponimines by substituting several electron donors along with the changing position of donors.

52 Recipients of an HLA-DR1 donor also have an impaired cardiovascular outcome.

53 d a similar likelihood of having an approved donor among African Americans compared with Caucasians.

54 s in temperature and pH, as well as electron donor and acceptor availability.

55 served and divergent structural features for donor and acceptor recognition and catalysis.

56 terium kansasii with and without evidence of donor and acceptor substrate binding obtained using a cr

57 These structures show how the donor and acceptor substrates bind in the active site an

58 reaction conditions and the type of glycosyl donor and acceptor used, can affect the outcome of glyco

59 egistrations, waitlist mortality, and living-donor and deceased-donor kidney transplants (LDKT/DDKT)

60 ylate derivatives (4a-i) containing electron-donor and electron-acceptor groups with remarkable photo

61 The triphenylamine donor and five cyanostilbene acceptor units of the macro

62 biota-derived hydrogen (H(2)) as an electron donor and fumarate as an electron acceptor.

63 Other variables impacting outcome include donor and recipient age, CC, non-DBD donor and reduced g

64 nverse probability of treatment weighting on donor and recipient characteristics, we found that 1-, 5

65 h-censored graft failure independent of both donor and recipient clinical characteristics included in

66 include donor and recipient age, CC, non-DBD donor and reduced graft size.

67 ghteen recipients received uteri from living donors and 2 from deceased donors.

68 e demonstrated higher likelihood of screened donors and a similar likelihood of having an approved do

69 se reactions, the RRV difference between the donors and acceptors had to be more than 6311 to obtain

70 bon linkages between the rotational electron donors and acceptors of RBFs.

71 carbazoles enrich the family of triarylamine donors and constitute a novel building block for functio

72 ention strategy via matching deceased kidney donors and recipients by CMV serostatus.

73 Testing donors and recipients for HHV-8 is currently challenging

74 ic for self-antigens such as MiHA in MiHApos donors and TAAs are present in peripheral blood of healt

75 blind analysis of blood smears from healthy donors and thrombocytopenic and sickle cell disease pati

76 PBMCs from healthy donors and/or respiratory epithelial cells were stimulat

77 e emission spectrum of benzimidazole (energy donor) and the absorption spectrum of thiadiazole (energ

78 oven in plasma from CRC patients and healthy donors, and full discrimination between mutated DNA from

79 f cf-mt-DNA elevated in older deceased organ donors, and with the isolated cf-mt-DNA capable of activ

80 nating and highly twisted nature of the TTAC donor as well as the spatially separated hole-particle w

81 heir cognate ligands can be used to classify donors as KIR-advantageous or KIR-disadvantageous.

82 ive of a potential regional phenomenon among donors as opposed to few donors with singularly high tit

83 dida Antarctica, and vinyl cinnamate as acyl donor at ratio 250:1 (acyl donor to anthocyanin).

84 rizontal gene transfer events from different donor bacteria that are part of the mammalian microbiome

85 dual endotoxin after successful treatment of donor bacterial pneumonia promotes PGD through ischemia/

86 Despite KT from octogenarian deceased donors being associated with reduced graft survival, rec

87 fore 2018), including baseline demographics, donor, biochemical and clinical data at LT, immunosuppre

88 middle cerebral artery occlusion using young donor biome (2-3 months) or aged biome (18-20 months).

89 The donor bladder with abdominal aorta and inferior vena cav

90 were transplanted 7 days postinjection with donor (bm1 or F1) and third-party B10.BR (H-2) skin graf

91 ied marked heterogeneity in animal models of donor brain death coupled to HTx, with few research grou

92 er circulatory determination of death (DCDD) donors but do not measure potential DCDD donors.

93 parameter used to accept or reject a living donor candidate.

94 ey aspect in the evaluation of living kidney donor candidates; however, data on performance of common

95 recisely tailored bis-thiourea hydrogen-bond-donor catalyst.

96 Donor cell engraftment within non-irradiated dystrophic

97 es can be a convenient resource for tracking donor cells in both syngenic MHC-matched and in allogeni

98 the persistence of transfused semiallogeneic donor cells mismatched at major histocompatibility class

99 techniques for distinguishing recipient from donor cells.

100 Recipient, operative, and donor characteristics during COVID-19 were similar to th

101 ongly increased in a subgroup of human organ donors characterized by prolonged duration of stay in an

102 -alloBMT in four patients with more than 95% donor chimerism, consistent with a 2.06-2.54 log(10) red

103 s associated with HHV-6 viremia in high-risk donor CMV-seropositive and recipient CMV-seronegative (D

104 pathway enrichment contrasted HF groups and donor controls.

105 Donor corneas were prestripped and precut for DMEK and U

106 Donor creatinine was 10.18 mg/dl with protein (30 mg/dl)

107 -minute video that featured registered organ donors, deceased donor families, and transplant recipien

108 guidance that recommended a change in blood donor deferral of men who have sex with men (MSM) from a

109 cause several metabolic parameters displayed donor dependency, LHM may also be used in studies for pe

110 Genome-edited donor-derived allogeneic anti-CD19 chimeric antigen rece

111 Here, we use matched donor-derived human dermal blood and lymphatic endotheli

112 nt immunoregulatory cells, we tested whether donor-derived MDSCs can protect heart transplant allogra

113 schemia-reperfusion injury on the ability of donor-derived resident renal macrophages to act as profe

114 allogeneic donor stem cells led to sustained donor-derived spermatogenesis.

115 While blood contained primarily donor-derived T cells, most T cells in the skin were hos

116 2) S donor thiol and its analogous N(4) S(2) donor disulfide ligands.

117 ation and provided different single-stranded donor DNA templates.

118 achieved from S-nitrosothiol (RSNO) type NO donor doped silicone rubber films using feedback-control

119 ck of robust outcomes data, lack of standard donor eligibility criteria and preservation methods, and

120 for organ sharing began collecting confirmed donor EVLP status) and June 2019.

121 t featured registered organ donors, deceased donor families, and transplant recipients.

122 The polymer has a donor fluorophore at its free end, such that FRET with a

123 between 2.0 and 8.0) to weekly healthy lean donor FMT versus placebo capsules for 6 weeks.

124 ks the first report where a photoactivatable donor for any analyte has been used to quantify intracel

125 without the supply of an extraneous electron donor for denitrification was established.

126 el-1 mice with SLAMF6 -/- mice, we generated donors for T cells lacking SLAMF6 and expressing a trans

127 iffered between syntelog versus translocated donor genes.

128 ive patients, adjusting for disease risk and donor group, RIC was significantly associated with incre

129 ins uncertain when receiving a kidney from a donor >=80 years old.

130 splantation in recipients with a kidney from donors >=80 years was 0.54 (95% confidence interval, 0.3

131 Nearly all donors had dementia; three (two pure LATE-NC and one pur

132 ; three (two pure LATE-NC and one pure ADNC) donors had mild cognitive impairment and another two don

133 less, the use of allogeneic CAR T cells from donors has many potential advantages over autologous app

134 kidney donation (LKD), especially for young donors, has become a real matter of concern in the trans

135 mouth cadaver study was designed on 21 fresh donor heads.

136 lar apical myocardial tissue from nonfailing donor hearts as well as R and nonresponders at LVAD impl

137 However, the demand for donor hearts significantly outweighs the supply.

138 received a conditioning regimen, infusion of donor hematopoietic cells, then immunosuppressive drugs

139 traditional FXM results are not directed to donor HLA 60.25% of the time and negative traditional FX

140 The median distance between the donor hospital and transplant center increased from 83 t

141 ssion by using various techniques to achieve donor hyporesponsiveness.

142 reperfusion.Conclusions: The composition of donor ILC subsets is altered after allograft reperfusion

143 Donor immune cells from 18 patients were characterized p

144 delicate balance between the activity of the donor immune system against malignant and nonmalignant c

145 ncentives can enhance accountability between donors, implementers, service providers, governments, an

146 s (HSs) are important electron acceptors and donors in soils and aquifers.

147 A)) is employed to partially replace polymer donors in the active layer of PBDB-T/Y1.

148 The Institute of Anatomy had 150 body donors in the time period from January 2018 to June 2019

149 Outcome metrics for living donors include patient survival, survival free of operat

150 reaction tolerates a range of acceptors and donors, including disaccharides.

151 Adult liver transplants from DO donors increased from 2% in 2002 to 15% in 2017, while p

152 Poor photoproduct yields are explained by donor-independent, fast charge recombination with rates

153 A substitution in FTSJ3 and a splice donor insertion in GH1 are strongly associated with MCM

154 Ultimately, a better understanding of how donor intrinsic immunity influences allograft acceptance

155 ucational interventions about increased risk donors (IRDs) are less effective in improving knowledge

156 s a novel strategy to minimize the number of donor islets required from either cadaveric or living do

157 tioning kidney, and categorized as: deceased-donor kidney transplant alone (DD-KA, 68%), living-donor

158 kidney transplant alone (DD-KA, 68%), living-donor kidney transplant alone (LD-KA, 30%), or SPK (2%).

159 Similarly, deceased donor kidney transplant volume dropped from 367 to 202 (

160 ensitization has enabled incompatible living donor kidney transplantation (ILDKT) across HLA/ABO barr

161 bserved racial and sex disparities in living donor kidney transplantation do not appear to be related

162 ist mortality, and living-donor and deceased-donor kidney transplants (LDKT/DDKT) March 15-April 30,

163 pproach makes more efficient use of deceased donor kidneys but reduces access to transplantation for

164 ity CD8+ T cell clones isolated from healthy donors killed CBFB-MYH11+ HLA-B*40:01+ AML cell lines an

165 ll BLs prefer scaffolds having electron pair donors: KPC-2 is preferentially inhibited by sulfonamide

166 ecipients, we studied 110,019 adult deceased-donor KT recipients between 2005 and 2017.

167 tion of a cationic C(3)-symmetric tripyridyl donor L.HNO(3) with cis-[(tmeda)Pd(NO(3))(2)] (M) [tmeda

168 indefinite to a 12-month deferral since the donor last had sex with a man.

169 Whether donor leukocytes persist within kidney transplants or pl

170 nts were grouped as having received a living donor liver allograft from either an offspring or a nono

171 In the mouse, donor liver CC1 null mutation augmented IRI-OLT (CC1-KO-

172 LD using data from the adult-to-adult living donor liver transplantation (A2ALL) study, which represe

173 We studied outcomes following living donor liver transplantation (LDLT) post-PVTT downstaging

174 and United Kingdom and resumption of living donor liver transplantation activity in India toward the

175 L-LLS requires expertise in both living donor liver transplantation and advanced laparoscopic li

176 ction in an in situ and ex situ model of rat donor liver transplantation.

177 rategy for maximizing the number of deceased donor liver transplants.

178 h chronic liver disease, listed for deceased donor livers January 1, 2005-December 31, 2017.

179 Donor livers with >=30% macrosteatosis (steatotic livers

180 Lymphatic vessels in the donor lung exhibited active sprouting toward the host at

181 tive oxygen species (ROS) increased in human donor lungs starting from the warm-ischemia phase and we

182 ed that, following skin transplantation, the donor mast cell-mediated senescence in FRCs was associat

183 sity of microbiomes before administration of donor material than fecal samples from nonresponders (P

184 There was no significant association between donor MDRO and either measure of organ utilization.

185 The age of the donors (median 82 years (range: 57-96)) is not critical

186 me in matched (MUD) and mismatched unrelated donor (mMUD) setting is not well defined.

187 dedness inversion, enabled by a halogen bond donor molecular switch, is unprecedented.

188 hough the patients received up to 1.3 x 1010 donor mononuclear cells before transplantation.

189 ept UKD was in part due to uncertainty about donor motivations and whether the practice was morally a

190 o achieved full (>95%) vs low-level (5%-49%) donor myeloid engraftment.

191 s end, we developed and implemented a Living Donor Navigator (LDN) Program at the University of Alaba

192 Studying FcgammaRIIIb derived from healthy donor neutrophils, we observed profound differences as c

193 ing typically involves recombination between donor nucleic acids and acceptor genomic sequences subje

194 2+) solvation sheath due to a higher Gutmann donor number (29.8) of DMSO than that (18) of H(2)O.

195 me uses NADPH-cytochrome P450 reductase as a donor of electrons and hydroxylates cinnamic acid to for

196 racterizing tumour transcriptomes from 1,188 donors of the Pan-Cancer Analysis of Whole Genomes (PCAW

197 7, while pediatric liver transplants from DO donors only increased from <1% to 3% in the same time.

198 as a result of surgical implantation of the donor organ.

199 The scarcity of donor organs may be addressed in the future by using pig

200 -seq data set distinguished recipient versus donor origin for all 81,139 cells examined.

201 agon, lipase, and/or trypsinogen in 78 organ donor pancreata from birth through adulthood in control

202 nzymes catalyse the transfer of PEA from the donor PE lipid substrate to the recipient lipid A molecu

203 e associated with 3.52 fewer expected kidney donors per 100 eligible deaths than non-Gulf States.

204 The donor plants prepared for regeneration purposes had 5.75

205 d immunoglobulin G levels were correlated in donor plasma units (rho = 0.938; P < .001) and in the cu

206 k-heterojunction devices based on narrow-gap donor polymers.

207 deration of DCD in FHF could help expand the donor pool in this subset of critically ill patients.

208 ivers) represent a possible expansion to the donor pool, but are frequently discarded as they are ass

209 nclude lack of knowledge about the potential donor pool, lack of robust outcomes data, lack of standa

210 space across a set of pH values and electron-donor potentials.

211 rns over the medical care given to potential donors predicted (non)registration.

212 ta on how kidney quality, measured by kidney donor profile index (KDPI), impacts KALT survival outcom

213 nts were allocated kidneys with lower Kidney Donor Profile Index (median 30% versus 35%, P < 0.001) b

214 ukocyte antigen antibodies (Anti-HLA Ab) for donor-recipient matching and patient risk stratification

215 blood mononuclear cells were collected from donor-recipient pairs at the time of transplantation, an

216 n the utilization rates (hearts transplanted/donors recovered) of HCV-uninfected (HCV-) to those of H

217 te identification card demographic and organ donor registration data from 5 states to estimate the as

218 predominantly white neighborhoods) on organ donor registration rates within a specified geography (c

219 Increases in organ donor registration were consistently observed in each DM

220 ines generated from SARS-CoV-2-naive healthy donors responded similarly to the C-terminal region of t

221 An unbiased RNA-sequencing analysis of 207 donors revealed an unprecedented level of heterogeneity

222 e standard for death and respecting the dead donor rule.

223 ution of Hb concentration within RBCs from a donor sample to be determined.

224 f Milan and 480 samples of prepandemic organ donor sera collected in 2010-2012.

225 SARS-CoV-2-uninfected donor sera exhibited specific neutralizing activity agai

226 Donor serum samples were evaluated by indirect immunoflu

227 r Organ Sharing-approved AC and the existing donor service area-/region-based allocation schemes.

228 Donor severe obesity was not associated with adverse pos

229 llograft sEV release and the extent to which donor sEVs might induce cross-dressing following liver a

230 alent long-term clinical outcomes based upon donor sex.

231 be a promising approach to counteract global donor shortage.

232 NPS as a donor shows significant aggregation induced emission enh

233 ponge with or without sutures in the palatal donor sites following connective tissue grafting via the

234 At the same time, they tolerate many donor sites, including basic nitrogen and numerous heter

235 acute rejection episode, malignancy, de novo donor specific antibody, posttransplant diabetes (PTD),

236 Presence/absence of AD-like pathology was donor-specific (reproducible between individual organoid

237 Currently, strategies used to reduce donor-specific alloantibodies are collectively called de

238 in PB and to analyze their relationship with donor-specific antibodies (DSA) and histological phenoty

239 -activating factor (BAFF) is associated with donor-specific antibodies (DSA) and poorer outcomes afte

240 to 4/18 non-HLA antigens synergize with HLA donor-specific antibodies and significantly increase the

241 azakizumab displayed significantly decreased donor-specific antibodies and, on prolonged treatment, m

242 lation highly expressed IL-18R1 and promoted donor-specific antibodies in response to IL-18 in vivo.

243 Reduction in donor-specific antibody (DSA) has been associated with i

244 tive traditional FXM results are missing HLA donor-specific antibody 36.2% of the time based on the D

245 LISA, anti-HLA-total IgG, IgG3 and IgG4, and donor-specific antibody by Luminex assay.

246 ulin (Ig), Qa-1 mutant mice developed robust donor-specific antibody responses and accelerated heart

247 enal allograft recipients with pretransplant donor-specific HLA antibodies (DSA) and its association

248 Renal function and donor-specific HLA-antibodies remained similar in both g

249 No donor-specific human leukocyte antigen Abs or rejection

250 as to investigate the presence of concurrent donor-specific memory B cell-derived HLA antibodies (DSA

251 anisms through which HCV infection modulates donor-specific T cell responses following LT and the inf

252 However, the basis of DGAT2's acyl-donor specificity is not known because of the inherent c

253 n adult pigs and goats, SSCT with allogeneic donor stem cells led to sustained donor-derived spermato

254 d not by the antiparallel orientation of the donor strand alone.

255 ecay with different electron-withdrawing or -donor substituents in the benzene ring are higher than t

256 tate and in complex with GDP, a mimic of the donor substrate, and with a glycopeptide acceptor substr

257 1A1 enzymatic activity compared with healthy donors, suggesting that dysregulation of the AHR/CYP1A1

258 hysiology distinct from acute GVHD, Itpkb-/- donor T cells reduced active chronic GVHD in a multiorga

259 and involves the modification of patient or donor T cells to target specific cell-surface antigens.

260 (APCs) to efficiently present alloantigen to donor T cells while releasing cytokines (eg, interleukin

261 differentiate both pathogenic and regulatory donor T cells.

262 depletion of host T(conv) and host T(regs), donor T(regs) failed to engraft even with interleukin-2

263 between the recombinogenic filament and the donor template in yeast, limiting strand rejection by th

264 reagents and a homologous recombination (HR) donor template into embryos to trigger homology directed

265 es without requiring double-strand breaks or donor templates.

266 as a FRET acceptor and is an efficient FRET donor that supports red/far-red FRET biosensing.

267 induced by introducing sacrificial electron donors that facilitate proton-coupled electron transfer.

268 Sulfur-based ligands are versatile donors that play important roles in a wide array of subd

269 KR) Advanced Donation Program enables living donors the opportunity to donate altruistically, or in a

270 iver transplant recipients with seropositive donors, the use of preemptive therapy, compared with ant

271 II) complexes comprising a tridentate N(2) S donor thiol and its analogous N(4) S(2) donor disulfide

272 cinnamate as acyl donor at ratio 250:1 (acyl donor to anthocyanin).

273 ntermediate that serves as a direct electron donor to mitochondrial complex II.

274 e model, we tested complement-blockade in BD donors to prevent DGF and improve graft survival.

275 obtain pre-symptomatic tissue from eye bank donors to probe how gene expression changes precede dise

276 The priority is to select uninfected donors to transplant uninfected recipients while maintai

277 otes PGD through ischemia/reperfusion-primed donor TRAMs.

278 nslocation to the plasma membrane of TLR4 in donor TRAMs.

279 l domains of life wherein prenyl diphosphate donors transfer prenyl groups onto small molecules as we

280 tion also occurred if CXCR4 was deleted from donor Tregs pre-transplant.

281 A vigorous anti-donor type T cell response was detected in vitro and con

282 h BALB/c MDSCs were transplanted with either donor-type (BALB/c, H2K(d), I-A(d)) or third-party (C3H,

283 This includes donor-unrestricted T cells (DURTs), such as mucosa-assoc

284 and 14 with severe disease) and 16 unexposed donors, using interferon-gamma-based assays with peptide

285 ansplant recipients and 2 transgender living donors was constructed and analyzed.

286 relapse of patients with a KIR-advantageous donor were comparable to patients with a KIR-disadvantag

287 Highly purified neutrophils from healthy donors were primed in vitro with a papillary TC or ATC c

288 ly isolated from peripheral blood of healthy donors were stimulated with different combinations of mo

289 a comparison group of infection-nonreactive donors were tested under blind using liquid chromatograp

290 Acyl-CoA thioesters were the preferred acyl donors, while acyl-ACP (acyl carrier protein), free fatt

291 s indicate that using sulfide as an electron donor will promote N(2) O and ammonium production, which

292 d of LT 2012-2015 (aHR, 0.58; P = 0.001) and donor with anoxic cause of death (aHR, 0.51; P = 0.007)

293 Four plasma samples from blood donors with acute HIV-1 infection and one viral culture

294 surgeons are more likely to discard deceased donors with acute kidney injury (AKI) versus without AKI

295 tau oligomers and pathological extracts from donors with AD and chronic traumatic encephalopathy.

296 Corneal samples were obtained from human donors with and without diabetes.

297 patients (34.4%) among the 90 potential lung donors with at least one other organ harvested (pneumoni

298 ad mild cognitive impairment and another two donors with LATE-NC did not have dementia.

299 al phenomenon among donors as opposed to few donors with singularly high titers.

300 profiling of four cortical areas across 364 donors with varying cognitive and neuropathological phen